Home

Oxygenta Pharmaceutical Ltd EPS

Image

Oxygenta Pharmaceutical Ltd

NSE: OXYGENTAPHARMA

EPS

₹ -0.1

Last updated on: May 09, 2025

Key Highlights

  • The Earning per Share of Oxygenta Pharmaceutical Ltd is ₹ -0.1 as of 09 May 25 .
  • The earning per share of Oxygenta Pharmaceutical Ltd changed from ₹ -1.65 to ₹ 1.07 over 7 quarters. This represents a CAGR of NaN% .

Historical Earning per Share of Oxygenta Pharmaceutical Ltd

No data available

* All values are in

Company Fundamentals for Oxygenta Pharmaceutical Ltd

Market Cap

296 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

0.0

Day’s High

82.68

Day’s Low

80.25

DTE

-2.9

ROE

-0.1

52 Week High

108.64

52 Week Low

30.0

ROCE

-24.5

Market Price of Oxygenta Pharmaceutical Ltd

1M

1Y

3Y

5Y

Monitoring Oxygenta Pharmaceutical Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 May 202580.3
08 May 202582.68
07 May 202584
06 May 202584.05
05 May 202585.37
02 May 202586.98
30 Apr 202583.38
29 Apr 202584.91
28 Apr 202591.11
25 Apr 202585.05

SWOT Analysis Of Oxygenta Pharmaceutical Ltd

Strength

0

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Oxygenta Pharmaceutical Ltd

Asset Value vs Market Value of Oxygenta Pharmaceutical Ltd

Market Value

297

Asset Value

Value addition

8.0 X

33

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Oxygenta Pharmaceutical Ltd296.98
Sun Pharmaceutical Industries Ltd418648
Divis Laboratories Ltd159310
Cipla Ltd119410
Torrent Pharmaceuticals Ltd106184
Mankind Pharma Ltd99570

Historical Market Cap of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Historical Revenue of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Historical EBITDA of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Historical Net Profit of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Oxygenta Pharmaceutical Ltd News Hub

Oxygenta Pharmaceutical reports standalone net loss of Rs 1.36 crore in the June 2024 quarter

Net Loss of Oxygenta Pharmaceutical reported to Rs 1.36 crore in the quarter ended June 2024 as agai

Read more

16 Aug 24

Oxygenta Pharmaceutical to discuss results

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 August 20

Read more

12 Aug 24

Oxygenta Pharmaceutical schedules AGM

Oxygenta Pharmaceutical announced that the 31th Annual General Meeting (AGM) of the company will be

Read more

18 Sept 24

Oxygenta Pharmaceutical announces board meeting date

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 November

Read more

11 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Oxygenta Pharmaceutical Ltd

What is the EPS of Oxygenta Pharmaceutical Ltd stock?

The Earnings Per Share (EPS) of Oxygenta Pharmaceutical Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Oxygenta Pharmaceutical Ltd EPS calculated?

The EPS of Oxygenta Pharmaceutical Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Oxygenta Pharmaceutical Ltd report its EPS?

Oxygenta Pharmaceutical Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Oxygenta Pharmaceutical Ltd EPS?

Factors that influence the EPS of Oxygenta Pharmaceutical Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Oxygenta Pharmaceutical Ltd EPS growth indicate future performance?

Yes, consistent growth in Oxygenta Pharmaceutical Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions